Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.
De Ruysscher D, Dehing C, Bremer RH, Bentzen SM, Koppe F, Pijls-Johannesma M, Harzée L, Minken A, Wanders R, Hochstenbag M, Dingemans AM, Boersma L, van Haren E, Geraedts W, Pitz C, Simons J, Wouters B, Rosier JF, Lambin P. De Ruysscher D, et al. Among authors: dingemans am. Ann Oncol. 2007 May;18(5):909-16. doi: 10.1093/annonc/mdm005. Epub 2007 Feb 23. Ann Oncol. 2007. PMID: 17322546 Free article.
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?
De Ruysscher D, Van Meerbeeck J, Vandecasteele K, Oberije C, Pijls M, Dingemans AM, Reymen B, van Baardwijk A, Wanders R, Lammering G, Lambin P, De Neve W. De Ruysscher D, et al. Among authors: dingemans am. Strahlenther Onkol. 2012 Jul;188(7):564-7. doi: 10.1007/s00066-012-0098-z. Epub 2012 Apr 29. Strahlenther Onkol. 2012. PMID: 22543884 Clinical Trial.
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M; IMpower150 Study Group. Socinski MA, et al. N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863955 Free article. Clinical Trial.
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer.
Houda I, Bahce I, Dickhoff C, Kroese TE, Kroeze SGC, Mariolo AV, Tagliamento M, Moliner L, Brandão M, Pretzenbacher Y, Edwards J, Opitz I, Brunelli A, Guckenberger M, van Schil PE, Popat S, Blum T, Faivre-Finn C, de Ruysscher D, Remon J, Berghmans T, Dingemans AC, Besse B, Hendriks LEL. Houda I, et al. Lung Cancer. 2024 Dec 15;199:108061. doi: 10.1016/j.lungcan.2024.108061. Online ahead of print. Lung Cancer. 2024. PMID: 39705827 Free article.
The DETECTION project part 1: An international Delphi survey about diagnostics and treatment of anterior mediastinal cystic lesions.
Marcuse F, Dumoulin D, Hartemink K, Hochstenbag M, Burgers S, Gietema HA, Mulders TA, Eryigit E, Maessen J, Maat L, Hamid MA, von der Thüsen J, Monkhorst K, Dingemans AC, Girard N. Marcuse F, et al. Lung Cancer. 2024 Dec 9;199:108055. doi: 10.1016/j.lungcan.2024.108055. Online ahead of print. Lung Cancer. 2024. PMID: 39657307 Free article.
OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary Carcinoid.
Moonen L, Derks JL, den Bakker MA, Hillen LM, van Suylen RJ, von der Thüsen JH, Lap LMV, Marijnissen BJCA, Damhuis RA, Smits KM, van den Broek EC, Buikhuisen WA; PALGA group; Dingemans AC, Speel EJM. Moonen L, et al. Mod Pathol. 2024 Dec 2;38(3):100677. doi: 10.1016/j.modpat.2024.100677. Online ahead of print. Mod Pathol. 2024. PMID: 39631518 Free article.
Sex and Common Germline Variants Affect the Toxicity Profile and Pharmacokinetics of Alectinib: A Nationwide Cohort Study in Patients With ALK-Positive NSCLC.
Heersche N, Lanser DAC, Muntinghe-Wagenaar MB, Mohmaed Ali MI, Ulas EB, Trooster TMA, de Jonge E, Oomen-de Hoop E, Paats MS, Bahce I, Croes S, Hendriks LEL, van der Wekken AJ, Dingemans AC, Huitema ADR, van Schaik RHN, Mathijssen RHJ, Veerman GDM. Heersche N, et al. J Thorac Oncol. 2024 Nov 29:S1556-0864(24)02488-2. doi: 10.1016/j.jtho.2024.11.025. Online ahead of print. J Thorac Oncol. 2024. PMID: 39617342 Free article.
Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids.
Leunissen DJG, Moonen L, von der Thüsen JH, den Bakker MA, Hillen LM, van Weert TJJ, Zur Hausen A, van den Bosch TPP, Lap LMV, Damhuis RA, Reynaert NL, van den Broek EC; PALGA group; Fernandez-Cuesta L, Foll M, Alcala N, Sexton-Oates A, Dingemans AC, Speel EM, Derks JL. Leunissen DJG, et al. J Thorac Oncol. 2024 Nov 22:S1556-0864(24)02481-X. doi: 10.1016/j.jtho.2024.11.018. Online ahead of print. J Thorac Oncol. 2024. PMID: 39581377 Free article.
330 results